Hot Pursuit     31-May-23
Spandana Sphoorty jumps over 13% in four days
Spandana Sphoorty Financial jumped 8.11% to Rs 716.05, extending gains for the fourth trading session in a row.
The company announced that its board will meet on 2 June 2023, to consider issue of non-convertible debentures on private placement basis.

Shares of Spandana Sphoorty Financial have risen 13.45% in four consecutive sessions.

The stock outperformed the market over the past one month, rising 20.63% compared with 2.39% increase in the Sensex.

The scrip outperformed the market in past one quarter, climbing 24.02% compared with 4.63% rise in the Sensex.

The scrip outperformed the market in past one year, rising 90.79% compared with 12.61% increase in the Sensex.

On the technical front, the stock's daily RSI (relative strength index) stood at 73.93. The RSI oscillates between zero and 100. Traditionally, the RSI is considered overbought when above 70 and oversold when below 30.

On the daily chart, the stock was trading above its 50-day, 100-day and 200-day simple moving average (SMA) placed at 594.56, 581.88 and 574.33, respectively. These levels will act as crucial support zones in near term.

Spandana Sphoorty Financial is a rural-focused non-banking financial company and a microfinance lender (NBFC-MFI) with a geographically diversified presence in India.

On a consolidated basis, the company's net profit jumped 48% to Rs 105.57 crore in Q4 FY23 compared with Rs 71.36 crore in Q3 FY23. Total income stood at Rs 533 crore in Q4 FY23, registering the growth of 42% as against Rs 375 crore posted in Q3 FY23.

Previous News
  Spandana Sphoorty Financial schedules board meeting
 ( Corporate News - 23-Aug-24   12:24 )
  Spandana Sphoorty Financial reports consolidated net loss of Rs 440.19 crore in the December 2024 quarter
 ( Results - Announcements 23-Jan-25   16:54 )
  Spandana Sphoorty Financial consolidated net profit rises 127.00% in the September 2023 quarter
 ( Results - Announcements 30-Oct-23   17:34 )
  Spandana Sphoorty Financial to raise Rs 100 cr via NCD issuance
 ( Corporate News - 16-Jan-24   19:19 )
  Spandana Sphoorty Financial allots 38,125 equity shares under ESOP
 ( Corporate News - 06-Mar-24   11:41 )
  Spandana Sphoorty Financial approves NCD issuance of up to Rs 50 cr
 ( Corporate News - 03-Oct-24   13:54 )
  CARE Ratings reaffirms 'A+' rating of Spandana Sphoorty with 'stable' outlook
 ( Hot Pursuit - 03-Oct-24   15:22 )
  Glaxosmithkline Pharmaceuticals Ltd leads gainers in 'A' group
 ( Hot Pursuit - 06-Feb-25   12:00 )
  Spandana Sphoorty Financial to convene board meeting
 ( Corporate News - 18-Oct-23   10:40 )
  Spandana Sphoorty Financial approves raising up to Rs 70 cr via NCDs
 ( Corporate News - 04-Mar-24   14:18 )
  Spandana Sphoorty Financial allots NCDs aggregating Rs 75 cr
 ( Corporate News - 12-Jun-23   21:52 )
Other Stories
  Axis Bank reports marginal decline in Q4 PAT to Rs 7,117.50 crore
  24-Apr-25   18:48
  Tech Mahindra Q4 PAT rises 19% QoQ; declares dividend of Rs 30/sh
  24-Apr-25   18:15
  Laurus Lab Q4 PAT soars to Rs 234 cr
  24-Apr-25   17:20
  SBI Life Q4 PAT rises to Rs 814 crore; net premium income slides 5%
  24-Apr-25   17:05
  Syngene slides on tepid results and toned-down forecast
  24-Apr-25   16:22
  ACC Q4 PAT tumbles 20% YoY to Rs 751 cr
  24-Apr-25   15:54
  Supreme Inds Q4 PAT drops 17% YoY to Rs 294 cr; declares dividend of Rs 24/sh
  24-Apr-25   15:01
  Syngene International Ltd leads losers in 'A' group
  24-Apr-25   15:00
  Spandana Sphoorty rallies as board appoints Ashish Kumar Damani as interim CEO
  24-Apr-25   14:56
  Refex Inds Q4 PAT climbs 41% YoY to Rs 48 cr
  24-Apr-25   14:46
Back Top